Francisco Ramírez-Valle
researcher (ORCID 0000-0002-8625-5869)
1 story
1 quote
We're building our pipeline around therapies that meaningfully change the course of disease, not just its downstream effects,
- said Francisco Ramírez-Valle, senior vice president, Lilly immunology research and early clinical developmentCNBCcnbc.com/2026/08…
Earlier
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
The Wall Street Journalwsj.com/health/pharma…Lilly has been on an acquisition spree following windfall profits from the success of its obesity drugs
CNBCcnbc.com/2026/08…